Latest Breaking News On - Pharma stock down - Page 6 : comparemela.com

China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at StockNews com

China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China pharma holdings incChina pharma company profileChina pharmaFree reportPharma stock downGet free reportPharma holdingsChina pharma daily

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews com

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China pharma holdings incChina pharmaFree reportPharma stock downGet free reportPharma holdingsChina pharma daily

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Monday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 2.9 % NASDAQ:EVOK opened at $1.32 on Monday. The company has a debt-to-equity ratio of 9.29, a current ratio of 3.50 […]

Pharma incEvoke pharmaFree reportPharma stock downGet free reportEvoke pharma dailyNasdaq evokInitiated coverageStocknews com

Cocrystal Pharma (NASDAQ:COCP) Stock Rating Reaffirmed by HC Wainwright

Cocrystal Pharma (NASDAQ:COCP) Stock Rating Reaffirmed by HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cocrystal pharmaExchange commissionCocrystal pharma incRenaissance technologiesGet free reportPharma stock downFree reportCocrystal pharma daily

Nuvectis Pharma, Inc (NASDAQ:NVCT) Short Interest Up 18 8% in November

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 345,600 shares, a growth of 18.8% from the October 31st total of 291,000 shares. Currently, 5.6% of the shares of the stock are […]

United statesNuvectis pharmaBaldwin brothersTower research capitalCharles schwab investment management incNuvectis pharma incGet free reportPharma stock downResearch capitalSchwab investment managementCalifornia state teachers retirement systemNuvectis pharma dailyNasdaq nvct